Disc Medicine, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Disc Medicine, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q2 2024.
  • Disc Medicine, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $4.09M, a 213% increase year-over-year.
  • Disc Medicine, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $11.3M, a 206% increase year-over-year.
  • Disc Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.53M, a 165% increase from 2022.
  • Disc Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.09M, a 312% increase from 2021.
  • Disc Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $507K, a 48.4% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $11.3M $4.09M +$2.78M +213% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $8.56M $4.06M +$3.03M +296% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $5.53M $1.93M +$934K +94.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $4.6M $1.27M +$888K +232% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $3.71M $1.31M +$927K +243% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $2.78M $1.02M +$692K +208% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.09M $993K +$6.6M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$4.51M $382K -$1.28M -77% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$3.23M $382K -$2.48M -86.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$754K $332K -$1.26M -79.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $507K -$5.61M -$6.2M -1050% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $6.7M $1.66M +$1.5M +930% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $5.21M $2.86M +$2.72M +1974% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $2.48M $1.59M +$1.5M +1595% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $983K $590K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $161K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $138K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $94K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.